$35.85+79.25% · 3M
Moving avg
1W+2.49%
1M+19.86%
3M+79.25%
6M+79.25%
YTD+79.25%
1Y+79.25%
3Y+79.25%
5Y+79.25%
52-week range
$24.5191% of range$36.95
Company health
Value0/6
Growth0/6
Profitability0/6
Health0/6
Dividend0/6
Key statistics
Valuation
Market cap
$4.18B
Enterprise value
$4.18B
P/E ratio (TTM)
-
P/S ratio (TTM)
-
EV/EBITDA
-
Per share & returns
EPS (TTM)
-
Dividend yield
-
Beta (1Y)
0.00
30-day change
+19.86%
Trading
Volume (24h)
89.66K
Previous close
$37.41
Shares outstanding
116.56M
About Parabilis Medicines, Inc.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Symbol
PBLS
Parabilis Medicines, Inc. is a mid-cap healthcare company in the Biotechnology industry. Its shares are listed on NASDAQ (United States) and trade under the ticker PBLS.
Frequently asked questions
What is Parabilis Medicines, Inc.'s market cap?
Parabilis Medicines, Inc. (PBLS) has a market capitalization of $4.18B.
What sector is Parabilis Medicines, Inc. in?
Parabilis Medicines, Inc. operates in the Healthcare sector, Biotechnology industry.
What exchange does PBLS trade on?
PBLS trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,218.39-0.15%
$1.15T cap
Johnson & JohnsonJNJ
$261.39+0.20%
$629.92B cap
AbbVie Inc.ABBV
$250.32+0.63%
$442.26B cap
UnitedHealth Group IncorporatedUNH
$402.17-0.84%
$365.22B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$355.30B cap
Merck & Co., Inc.MRK
$134.77+1.39%
$332.86B cap
Novartis AGSWX: NOVN
CHF 123.74-0.37%
$289.76B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.27B cap